BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2164121)

  • 1. Characterization of sublines of HL-60 human leukemia cells resistant to induction of differentiation by butyric acid.
    Fischkoff SA; Hoessly MC; Rossi RM
    Leukemia; 1990 Apr; 4(4):302-6. PubMed ID: 2164121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors responsible for variable reported lineages of HL-60 cells induced to mature with butyric acid.
    Hoessly MC; Rossi RM; Fischkoff SA
    Cancer Res; 1989 Jul; 49(13):3594-7. PubMed ID: 2567205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lineage directed HL-60 cell sublines as a model system for the study of early events in lineage determination of myeloid cells.
    Fischkoff SA; Rossi RM
    Leuk Res; 1990; 14(11-12):979-88. PubMed ID: 2177814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of differentiation-inducer-resistant HL-60 cells.
    Gallagher RE; Bilello PA; Ferrari AC; Chang CS; Yen RW; Nickols WA; Muly EC
    Leuk Res; 1985; 9(8):967-86. PubMed ID: 3862924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RB phosphorylation in sodium butyrate-resistant HL-60 cells: cross-resistance to retinoic acid but not vitamin D3.
    Yen A; Varvayanis S
    J Cell Physiol; 1995 Jun; 163(3):502-9. PubMed ID: 7775593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemic cell maturation: variability of the myeloid leukemic cell phenotype.
    Ross DW; Pryzwansky KB; Prenant M; Dent G
    Blood Cells; 1986; 12(1):139-51. PubMed ID: 3466656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
    Breitman TR; He RY
    Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
    Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
    Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3.
    Sokoloski JA; Shyam K; Sartorelli AC
    Oncol Res; 1997; 9(1):31-9. PubMed ID: 9112258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of calcium in differentiation of leukemic cell lines.
    Rephaeli A; Aviram A; Rabizadeh E; Englender T; Shaklai M
    Cancer Biochem Biophys; 1990 Apr; 11(2):119-25. PubMed ID: 2383856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of HL-60 cell variants with different potentials for spontaneous differentiation.
    Fibach E; Peled T; Fibich T; Rachmilewitz EA
    Leukemia; 1991 Oct; 5(10):912-6. PubMed ID: 1961026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a granulocytic subclone (UM 384) from the monoblastic cell line U 937.
    Champelovier P; Seigneurin D; Leroux D; Micouin C; Kolodie L
    Exp Hematol; 1989 Aug; 17(7):779-84. PubMed ID: 2753087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
    Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
    Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid.
    Drach J; Lopez-Berestein G; McQueen T; Andreeff M; Mehta K
    Cancer Res; 1993 May; 53(9):2100-4. PubMed ID: 8481912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of a WEHI-3B D+ monomyelocytic leukemia cell line resistant to novobiocin and cross-resistant to other topoisomerase II-targeted drugs.
    Rappa G; Lorico A; Sartorelli AC
    Cancer Res; 1992 May; 52(10):2782-90. PubMed ID: 1316227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
    Mann KK; Rephaeli A; Colosimo AL; Diaz Z; Nudelman A; Levovich I; Jing Y; Waxman S; Miller WH
    Mol Cancer Res; 2003 Oct; 1(12):903-12. PubMed ID: 14573791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
    Miyaura C; Abe E; Suda T; Kuroki T
    Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of the histone H1 zero gene in U937 and HL-60 leukemia cell lines.
    Hochhuth C; Doenecke D
    J Cell Biochem; 1992 Nov; 50(3):316-23. PubMed ID: 1469067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of leukocyte adherence-related glycoproteins during differentiation of HL-60 promyelocytic leukemia cells.
    Hickstein DD; Smith A; Fisher W; Beatty PG; Schwartz BR; Harlan JM; Root RK; Locksley RM
    J Immunol; 1987 Jan; 138(2):513-9. PubMed ID: 2947951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased activity of acetyl-CoA carboxylase during chemically induced neutrophilic differentiation of human promyelocytic leukemia cells.
    Fischkoff SA; Papuchis GC; Nickols WA
    J Cell Biochem; 1984; 26(2):75-81. PubMed ID: 6151950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.